LESLIE VIVIANA BRZOZOWSKI

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SAN ANGELO, TX NPI 1821861733

General Payments — all program years on this page

$591.05

  • Category: General Payments
  • Program years: PY2024
  • Record count: 19
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $591.05 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $591.0519

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $224.407
Lilly USA, LLC $115.492
ABBVIE INC. $85.882
Ethicon US, LLC $65.421
Amgen Inc. $55.644
Novo Nordisk AS $44.223

By program year

Program yearAmountRecords
2024 $591.0519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077649236 Ethicon US, LLC $65.42 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100248778 Novo Nordisk Inc $13.37 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100340958 Novo Nordisk Inc $13.92 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100388875 Novo Nordisk Inc $16.93 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104237651 AstraZeneca Pharmaceuticals LP $15.52 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104467456 AstraZeneca Pharmaceuticals LP $14.40 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104603502 AstraZeneca Pharmaceuticals LP $18.34 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105475463 AstraZeneca Pharmaceuticals LP $128.25 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105576400 AstraZeneca Pharmaceuticals LP $13.75 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105654134 AstraZeneca Pharmaceuticals LP $15.87 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105885309 AstraZeneca Pharmaceuticals LP $18.27 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106841970 ABBVIE INC. $18.91 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106841972 ABBVIE INC. $66.97 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117516245 Amgen Inc. $13.34 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117516247 Amgen Inc. $15.21 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117516249 Amgen Inc. $13.89 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117516251 Amgen Inc. $13.20 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135788894 Lilly USA, LLC $16.50 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135814157 Lilly USA, LLC $98.99 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.